These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11406188)

  • 1. Novel AMPA receptor potentiators LY392098 and LY404187: effects on recombinant human AMPA receptors in vitro.
    Miu P; Jarvie KR; Radhakrishnan V; Gates MR; Ogden A; Ornstein PL; Zarrinmayeh H; Ho K; Peters D; Grabell J; Gupta A; Zimmerman DM; Bleakman D
    Neuropharmacology; 2001 Jun; 40(8):976-83. PubMed ID: 11406188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological effects of AMPA receptor potentiators LY392098 and LY404187 on rat neuronal AMPA receptors in vitro.
    Gates M; Ogden A; Bleakman D
    Neuropharmacology; 2001 Jun; 40(8):984-91. PubMed ID: 11406189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator.
    Baumbarger PJ; Muhlhauser M; Zhai J; Yang CR; Nisenbaum ES
    J Pharmacol Exp Ther; 2001 Jul; 298(1):86-102. PubMed ID: 11408529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LY392098, a novel AMPA receptor potentiator: electrophysiological studies in prefrontal cortical neurons.
    Baumbarger P; Muhlhauser M; Yang CR; Nisenbaum ES
    Neuropharmacology; 2001 Jun; 40(8):992-1002. PubMed ID: 11406190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LY404187: a novel positive allosteric modulator of AMPA receptors.
    Quirk JC; Nisenbaum ES
    CNS Drug Rev; 2002; 8(3):255-82. PubMed ID: 12353058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of responses to AMPA on central neurones by LY392098 and LY404187 in vivo.
    Vandergriff J; Huff K; Bond A; Lodge D
    Neuropharmacology; 2001 Jun; 40(8):1003-9. PubMed ID: 11406191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple molecular determinants for allosteric modulation of alternatively spliced AMPA receptors.
    Quirk JC; Nisenbaum ES
    J Neurosci; 2003 Nov; 23(34):10953-62. PubMed ID: 14645491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable expression of recombinant AMPA receptor subunits: binding affinities and effects of allosteric modulators.
    Hennegriff M; Arai A; Kessler M; Vanderklish P; Mutneja MS; Rogers G; Neve RL; Lynch G
    J Neurochem; 1997 Jun; 68(6):2424-34. PubMed ID: 9166736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMPA receptor potentiators for the treatment of CNS disorders.
    O'Neill MJ; Bleakman D; Zimmerman DM; Nisenbaum ES
    Curr Drug Targets CNS Neurol Disord; 2004 Jun; 3(3):181-94. PubMed ID: 15180479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of BDNF expression in primary neuron culture by LY392098, a novel AMPA receptor potentiator.
    Legutko B; Li X; Skolnick P
    Neuropharmacology; 2001 Jun; 40(8):1019-27. PubMed ID: 11406193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profiles.
    Bleakman D; Ballyk BA; Schoepp DD; Palmer AJ; Bath CP; Sharpe EF; Woolley ML; Bufton HR; Kamboj RK; Tarnawa I; Lodge D
    Neuropharmacology; 1996; 35(12):1689-702. PubMed ID: 9076748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of oligodendroglial excitotoxicity.
    Yoshioka A; Bacskai B; Pleasure D
    J Neurosci Res; 1996 Nov; 46(4):427-37. PubMed ID: 8950702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable expression of human homomeric and heteromeric AMPA receptor subunits in HEK293 cells.
    Nishimura S; Iizuka M; Wakamori M; Akiba I; Imoto K; Barsoumian EL
    Recept Channels; 2000; 7(2):139-50. PubMed ID: 10952090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization, localization, and regulation of ionotropic glutamate receptors in skate horizontal cells.
    Kreitzer MA; Birnbaum AD; Qian H; Malchow RP
    Vis Neurosci; 2009; 26(4):375-87. PubMed ID: 19678977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterisation of homomeric ionotropic glutamate receptors GluR1-GluR6 in a fluorescence-based high throughput screening assay.
    Strange M; Bräuner-Osborne H; Jensen AA
    Comb Chem High Throughput Screen; 2006 Feb; 9(2):147-58. PubMed ID: 16475972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of an AMPA receptor potentiator ([3H]LY395153) to native and recombinant AMPA receptors.
    Lindén AM; Yu H; Zarrinmayeh H; Wheeler WJ; Skolnick P
    Neuropharmacology; 2001 Jun; 40(8):1010-8. PubMed ID: 11406192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NS-257, a novel competitive AMPA receptor antagonist, interacts with kainate and NMDA receptors.
    Nijholt I; Blank T; Grafelmann B; Cepok S; Kügler H; Spiess J
    Brain Res; 1999 Mar; 821(2):374-82. PubMed ID: 10064824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of kinetic properties of GluR2 AMPA receptor channels by alternative splicing.
    Koike M; Tsukada S; Tsuzuki K; Kijima H; Ozawa S
    J Neurosci; 2000 Mar; 20(6):2166-74. PubMed ID: 10704491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characteristics of non-NMDA-type ionotropic glutamate receptor channels in AII amacrine cells in rat retina.
    Mørkve SH; Veruki ML; Hartveit E
    J Physiol; 2002 Jul; 542(Pt 1):147-65. PubMed ID: 12096058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism and impact of allosteric AMPA receptor modulation by the ampakine CX546.
    Nagarajan N; Quast C; Boxall AR; Shahid M; Rosenmund C
    Neuropharmacology; 2001 Nov; 41(6):650-63. PubMed ID: 11640919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.